Key Takeaway: MiMedx Group, Inc. announced its participation in two upcoming investor conferences in New York. Senior management will engage in one-on-one sessions at the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025, and the Canaccord MedTech, Diagnostics and Digital Health & Services Forum on November 20, 2025. This engagement reflects the company's focus on investor relations and commitment to its innovative healing solutions.
Price reaction · baseline $7.71 (2025-11-10 close) · hit after-hours · 1 other MDXG headline(s) in the window, move may be shared
day 0 close · peak
-2.2%
Market Sentiment Analysis
POSITIVE FACTORS
MiMedx is actively engaging with investors through conferences.
The company showcases its commitment to innovation in healing solutions.
Participation in notable investor events indicates strong market presence.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~40 mo
Low dilution risk
Lead asset
Micronized DHACM
Phase 3 · Tendonitis;Achilles
Full Press Release Details
MARIETTA, Ga., Nov. 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Craig-Hallum 16thAnnual Alpha Select Conference | New York, NYTuesday, November 18, 20251:1 sessions
Canaccord MedTech, Diagnostics and Digital Health & Services Forum | New York, NYThursday, November 20, 20251:1 sessions
Investors interested in meeting with senior management at these events may contact their respective Craig-Hallum or Canaccord representative.
About MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visitwww.mimedx.com.